Cargando…

Evaluation of IL-29 in Euthyroid Patients with Graves' Orbitopathy: A Preliminary Study

BACKGROUND: The most frequent cause of hyperthyroidism is Graves' disease (GD). Orbitopathy is the most prevalent and recognizable extrathyroidal manifestation of Graves' disease with unrevealed pathogenesis. Interleukin 29 (IL-29) is a relatively newly discovered inflammatory cytokine. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falkowski, Bogusz, Szczepanek-Parulska, Ewelina, Sawicka-Gutaj, Nadia, Krygier, Aleksandra, Ruchala, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368201/ https://www.ncbi.nlm.nih.gov/pubmed/32694926 http://dx.doi.org/10.1155/2020/4748612

Ejemplares similares

IgG4 as a Biomarker in Graves' Orbitopathy
por: Olejarz, Michał, et al.
Publicado: (2021)

High IgG4 serum concentration is associated with active Graves orbitopathy
por: Olejarz, Michał, et al.
Publicado: (2023)

Unexpected conversion from hypothyroidism to an euthyroid state due to Graves’ disease in a patient with an ectopic thyroid
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2013)

Changes in serum hepcidin according to thyrometabolic status in patients with Graves’ disease
por: Krygier, Aleksandra, et al.
Publicado: (2020)

Novel Biochemical Markers of Neurovascular Complications in Type 1 Diabetes Patients
por: Falkowski, Bogusz, et al.
Publicado: (2020)

Severe unilateral orbitopathy in a patient with Hashimoto’s thyroiditis - a case report
por: Cyranska-Chyrek, Ewa, et al.
Publicado: (2019)

“Slipped capital femoral epiphysis in a 25-year-old hypogonadic man with a large cranial chondroma: causality or coincidence? “
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021)

The hepcidin concentration decreases in hypothyroid patients with Hashimoto’s thyroiditis following restoration of euthyroidism
por: Hernik, Aleksandra, et al.
Publicado: (2019)

Eye symptoms in patients with benign thyroid diseases
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021)

Iron Homeostasis and Hepcidin Concentration in Patients With Acromegaly
por: Krygier, Aleksandra, et al.
Publicado: (2022)

Selected Organ and Endocrine Complications According to BMI and the Metabolic Category of Obesity: A Single Endocrine Center Study
por: Milewska, Ewa Malwina, et al.
Publicado: (2022)

Effect of restoration of euthyroidism on visfatin concentrations and body composition in women
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021)

Clinical, Biochemical, and Sonographic Factors Influencing Performance of Parathormone Washout Measurement vs. (99m)Tc-MIBI Scintigraphy in the Preoperative Diagnostics of Parathyroid Adenomas
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2023)

Clinical experience in the management of patients with Graves' orbitopathy treated according to the novel protocol of glucocorticoid therapy designed in the Department of Endocrinology, Metabolism and Internal Medicine of Poznan University of Medical Sciences
por: Sowiński, Jerzy, et al.
Publicado: (2013)

Imaging techniques in diagnostics, differentiation and monitoring of different types of thyroiditis
por: Ruchała, Marek, et al.
Publicado: (2013)

Editorial on the Special Issue “Novel Methods of Diagnostics of Thyroid and Parathyroid Lesions”
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2022)

Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves’ opthalmopathy
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2016)

Orbital Lymphoma Masquerading as Euthyroid Orbitopathy
por: Sharif, Muhammad Waqar, et al.
Publicado: (2023)

Interplay between Fatty Acid Binding Protein 4, Fetuin-A, Retinol Binding Protein 4 and Thyroid Function in Metabolic Dysregulation
por: Dadej, Daniela, et al.
Publicado: (2022)

Graves' Orbitopathy
por: Hiromatsu, Yuji, et al.
Publicado: (2015)

Editorial: Novel Imaging Techniques in the Management of Thyroid Nodules and Autoimmune Thyroid Disease
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2019)

Risk of neoplasms in acromegaly
por: Ruchała, Marek, et al.
Publicado: (2012)

Cushing’s syndrome is associated with altered adipokine profile
por: Dadej, Daniela, et al.
Publicado: (2022)

Asymmetric Graves’ Orbitopathy
por: Panagiotou, Grigorios, et al.
Publicado: (2020)

Malignancy Risk and Hormonal Activity of Adrenal Incidentalomas in a Large Cohort of Patients from a Single Tertiary Reference Center
por: Cyranska-Chyrek, Ewa, et al.
Publicado: (2019)

Electrocardiographic and scintigraphic evaluation of patients with subclinical hyperthyroidism during workout
por: Kaminski, Grzegorz, et al.
Publicado: (2016)

Radioiodine therapy and Graves’ disease – Myths and reality
por: Plazinska, Maria Teresa, et al.
Publicado: (2020)

The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
por: Hou, Jueyu, et al.
Publicado: (2021)

Thyroid nodule as a first manifestation of Hodgkin lymphoma–report of two cases and literature review
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2013)

Dependence of Thyroid Sonographic Markers of Malignancy and Its Influence on the Diagnostic Value of Sonographic Findings
por: Woliński, Kosma, et al.
Publicado: (2015)

Antioxidant Therapy in Graves’ Orbitopathy
por: Lanzolla, Giulia, et al.
Publicado: (2020)

Current Knowledge on Graves’ Orbitopathy
por: Gontarz-Nowak, Katarzyna, et al.
Publicado: (2020)

Orbital Signaling in Graves’ Orbitopathy
por: Draman, Mohd Shazli, et al.
Publicado: (2021)

The potential utility of the SAGIT instrument in the clinical assessment of patients with acromegaly, a large single-centre study
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2023)

Serum Visfatin/NAMPT as a Potential Risk Predictor for Malignancy of Adrenal Tumors
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2022)

Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
por: Derwich, Aleksandra, et al.
Publicado: (2023)

The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review
por: Derwich, Aleksandra, et al.
Publicado: (2023)

Does TSH Trigger the Anti-thyroid Autoimmune Processes? Observation on a Large Cohort of Naive Patients with Thyroid Hemiagenesis
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2016)

Graves’ disease and Graves’ orbitopathy following COVID-19
por: Lanzolla, G., et al.
Publicado: (2021)

Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
por: Lanzolla, G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s6osqb00mn4q73t9hu0o0rhuke